相似文献
1
Synthesis and conformation-activity relationships of the peptide isosteres of FK228 and largazole.
J Am Chem Soc. 2009 Mar 4;131(8):2900-5. doi: 10.1021/ja807772w.
2
Evaluation of class I HDAC isoform selectivity of largazole analogues.
Bioorg Med Chem Lett. 2014 Aug 15;24(16):3728-31. doi: 10.1016/j.bmcl.2014.07.006. Epub 2014 Jul 9.
3
Synthesis and biological evaluation of largazole zinc-binding group analogs.
Bioorg Med Chem. 2017 Jun 15;25(12):3077-3086. doi: 10.1016/j.bmc.2017.03.071. Epub 2017 Apr 4.
4
Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor.
J Am Chem Soc. 2008 Aug 20;130(33):11219-22. doi: 10.1021/ja8033763. Epub 2008 Jul 19.
5
Modular synthesis and biological activity of pyridyl-based analogs of the potent Class I Histone Deacetylase Inhibitor Largazole.
Bioorg Med Chem. 2015 Aug 1;23(15):5061-5074. doi: 10.1016/j.bmc.2015.03.063. Epub 2015 Mar 31.
6
Synthesis and biological evaluation of largazole analogues with modified surface recognition cap groups.
Eur J Med Chem. 2014 Oct 30;86:528-41. doi: 10.1016/j.ejmech.2014.09.009. Epub 2014 Sep 6.
7
Largazole Analogues as Histone Deacetylase Inhibitors and Anticancer Agents: An Overview of Structure-Activity Relationships.
ChemMedChem. 2017 Dec 7;12(23):1917-1926. doi: 10.1002/cmdc.201700563. Epub 2017 Nov 17.
8
Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs.
Bioorg Med Chem Lett. 2013 Nov 1;23(21):6025-8. doi: 10.1016/j.bmcl.2013.06.012. Epub 2013 Jun 18.
9
Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability.
Bioorg Med Chem. 2011 Jun 15;19(12):3650-8. doi: 10.1016/j.bmc.2011.02.024. Epub 2011 Feb 17.
10
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.
J Med Chem. 2016 Feb 25;59(4):1613-33. doi: 10.1021/acs.jmedchem.5b01632. Epub 2016 Jan 7.
引用本文的文献
1
Progress in the discovery and development of anticancer agents from marine cyanobacteria.
Nat Prod Rep. 2025 Feb 19;42(2):208-256. doi: 10.1039/d4np00019f.
2
Recent advances in the synthesis and utility of thiazoline and its derivatives.
RSC Adv. 2024 Jan 2;14(2):902-953. doi: 10.1039/d3ra06444a.
3
Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):675-702. doi: 10.1007/s00210-023-02674-4. Epub 2023 Aug 24.
4
LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.
Clin Transl Med. 2022 Jan;12(1):e703. doi: 10.1002/ctm2.703.
5
Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects.
Blood Cells Mol Dis. 2022 Mar;93:102626. doi: 10.1016/j.bcmd.2021.102626. Epub 2021 Nov 17.
6
Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts.
ACS Pharmacol Transl Sci. 2021 May 27;4(3):1136-1148. doi: 10.1021/acsptsci.1c00033. eCollection 2021 Jun 11.
7
Conformational analysis of macrocycles: comparing general and specialized methods.
J Comput Aided Mol Des. 2020 Mar;34(3):231-252. doi: 10.1007/s10822-020-00277-2. Epub 2020 Jan 21.
8
Synthesis and Biochemical Evaluation of Biotinylated Conjugates of Largazole Analogues: Selective Class I Histone Deacetylase Inhibitors.
Isr J Chem. 2017 Apr;57(3-4):319-330. doi: 10.1002/ijch.201600130. Epub 2017 Jan 27.
9
Microwave-assisted synthesis and antitumor evaluation of a new series of thiazolylcoumarin derivatives.
EXCLI J. 2017 Aug 30;16:1114-1131. doi: 10.17179/excli2017-208. eCollection 2017.
10
Modular synthesis and biological activity of pyridyl-based analogs of the potent Class I Histone Deacetylase Inhibitor Largazole.
Bioorg Med Chem. 2015 Aug 1;23(15):5061-5074. doi: 10.1016/j.bmc.2015.03.063. Epub 2015 Mar 31.
本文引用的文献
1
Optimization of a series of potent and selective ketone histone deacetylase inhibitors.
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5528-32. doi: 10.1016/j.bmcl.2008.09.003. Epub 2008 Sep 6.
2
Residues in the 11 A channel of histone deacetylase 1 promote catalytic activity: implications for designing isoform-selective histone deacetylase inhibitors.
J Med Chem. 2008 Sep 25;51(18):5542-51. doi: 10.1021/jm800081j. Epub 2008 Aug 27.
3
Enantioselective total synthesis of (+)-largazole, a potent inhibitor of histone deacetylase.
Org Lett. 2008 Sep 4;10(17):3907-9. doi: 10.1021/ol8014623. Epub 2008 Jul 29.
4
Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor.
J Am Chem Soc. 2008 Aug 20;130(33):11219-22. doi: 10.1021/ja8033763. Epub 2008 Jul 19.
5
A concise total synthesis of largazole, solution structure, and some preliminary structure activity relationships.
Org Lett. 2008 Aug 21;10(16):3595-8. doi: 10.1021/ol8013478. Epub 2008 Jul 11.
6
Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.
J Am Chem Soc. 2008 Jul 2;130(26):8455-9. doi: 10.1021/ja8013727. Epub 2008 May 29.
7
Structural origin of selectivity in class II-selective histone deacetylase inhibitors.
J Med Chem. 2008 May 22;51(10):2898-906. doi: 10.1021/jm7015254. Epub 2008 Apr 16.
8
Improved total synthesis of the potent HDAC inhibitor FK228 (FR-901228).
Org Lett. 2008 Feb 21;10(4):613-6. doi: 10.1021/ol702957z. Epub 2008 Jan 19.
9
Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.
J Am Chem Soc. 2008 Feb 13;130(6):1806-7. doi: 10.1021/ja7110064. Epub 2008 Jan 19.
10
Fluorous-based small-molecule microarrays for the discovery of histone deacetylase inhibitors.
Angew Chem Int Ed Engl. 2007;46(42):7960-4. doi: 10.1002/anie.200703198.
Zotero 插件